Clinical Update: Cholera Vaccine for Travelers

Friday, January 25, 2019 10:50 AM | Anonymous

Cholera is a disease spread by drinking water or eating food contaminated with toxigenic Vibrio cholerae bacteria. Severe cholera is characterized by large amounts of watery diarrhea, often described as “rice-water stool” because it can have a pale, milky appearance. It can also be accompanied by nausea and vomiting. If untreated, the loss of fluid can be deadly. But simple treatment, including replacing lost body fluids, can lower mortality to less than 1%. From 2010 through 2014, 91 cases of cholera were confirmed in the United States among people who had traveled internationally in the week before illness onset. Of these, 75% were associated with travel to the Caribbean, and 10% were associated with travel to India or Pakistan. Cholera can be prevented by heeding food and water precautions and receiving cholera vaccine before travel.

During this COCA Call, CDC travel medicine subject matter expert and infectious diseases physician Dr. Kristina Angelo and food and water expert Dr. Erin Connors will

  • Highlight critical information about cholera biology and prevention;
  • Discuss strategies primary care providers and medical subspecialists can use to decrease the likelihood of cholera illness in their patients; and
  • Review CDC resources on the epidemiology of cholera vaccine to use in clinical decision making about offering vaccine to patients.

Cholera

Date: Thursday, February 7, 2019

Time: 2:00-3:00 PM ET

A few minutes before the webinar begins, please click the link below to join the webinar:

https://zoom.us/j/883825945

Or iPhone one-tap:

US: +16468769923,,883825945# or +16699006833,,883825945#

Or Telephone:

US: +1 646 876 9923 or +1 669 900 6833

Webinar ID: 883 825 945

International numbers available here: https://zoom.us/u/abM1dOdLqM

The recordings (audio, slides, and transcript) for this call will be posted on the webpage a week after the COCA Call.

Free Continuing Education (CE) is available for most COCA Calls. Please see below for instructions on how to receive CE.

Activity Specific Objectives

At the conclusion of this COCA Call, the participant will be able to accomplish the following:

  • Describe cholera as an infectious agent. 
  • Identify key transmission routes of cholera. 
  • List recommendations for prevention strategies for cholera.
  • Discuss cholera vaccine recommendations and CDC resources for cholera vaccine.

COCA Call Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.

Presenters

Kristina M. Angelo, DO, MPH&TM

Medical Epidemiologist

Travelers’ Health Branch

Division of Global Migration and Quarantine

National Center for Emerging and Zoonotic Infectious Diseases

Centers for Disease Control and Prevention

 

Erin Conners, PhD, MPH

Epidemic Intelligence Officer

Waterborne Disease Prevention Branch

Division of Foodborne, Waterborne, and Environmental Diseases

National Center for Emerging and Zoonotic Infectious Diseases

Centers for Disease Control and Prevention

Instructions for Obtaining Continuing Education (CE)

To receive continuing education (CE) for WC2922-020719 – (Webcast) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – "Clinical Update: Cholera Vaccine for Travelers" – February 7, 2019 please visit TCEO and follow these 9 Simple Steps by March 11, 2019.

To receive continuing education (CE) for WD2922-020719 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – "Clinical Update: Cholera Vaccine for Travelers" – February 7, 2019 (Web on Demand), please visit TCEO and follow these 9 Simple Steps by March 8, 2021.

Accreditation Statements

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-19-057-L04-P and enduring 0387-0000-19-057-H04-P course category.

This activity has been designated as Knowledge-Based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credit for this program.

AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC did not accept commercial support for this continuing education activity.

Powered by Wild Apricot Membership Software